Global ePRO, e-Patient Diaries and eCOA Market by PerfOs (Performance Outcomes), by Application (Clinical Trial SponsorsContract Research Organizations (Contract Research Organizations CROs, Clinical Trial Sponsors), by Solution Type (eCOA (eCOA Electronic Clinical Outcome Assessments), by ObsROs (Observer Reported Outcomes), by ClinROs (Clinician Reported Outcomes), by EPROs (Patient Reported Outcomes), by Modality Type (Computer Mobile Devices (Tablets, Mobile Devices Smartphones, Computer) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Up Market Research published a new report titled “ePRO, e-Patient Diaries and eCOA Market research report which is segmented by PerfOs (Performance Outcomes), by Application (Clinical Trial SponsorsContract Research Organizations (Contract Research Organizations CROs, Clinical Trial Sponsors), by Solution Type (eCOA (eCOA Electronic Clinical Outcome Assessments), by ObsROs (Observer Reported Outcomes), by ClinROs (Clinician Reported Outcomes), by EPROs (Patient Reported Outcomes), by Modality Type (Computer Mobile Devices (Tablets, Mobile Devices Smartphones, Computer), By Players/Companies Medidata Solutions Inc., ERT Clinical, Health Diary Inc., PAREXEL International Corporation, OmniComm Systems Inc., Major players analyzed include Bracket Global LLC, SAS, Kayentis, ICON plc, Others., ArisGlobal LLC, CRF Health Inc.”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | ePRO, e-Patient Diaries and eCOA Market Research Report |
| By PerfOs | Performance Outcomes |
| By Application (Clinical Trial SponsorsContract Research Organizations | Contract Research Organizations CROs, Clinical Trial Sponsors |
| By Solution Type (eCOA | eCOA Electronic Clinical Outcome Assessments |
| By ObsROs | Observer Reported Outcomes |
| By ClinROs | Clinician Reported Outcomes |
| By EPROs | Patient Reported Outcomes |
| By Modality Type (Computer Mobile Devices | Tablets, Mobile Devices Smartphones, Computer |
| By Companies | Medidata Solutions Inc., ERT Clinical, Health Diary Inc., PAREXEL International Corporation, OmniComm Systems Inc., Major players analyzed include Bracket Global LLC, SAS, Kayentis, ICON plc, Others., ArisGlobal LLC, CRF Health Inc. |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 218 |
| Number of Tables & Figures | 153 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global ePRO, e-Patient Diaries and eCOA Market Report Segments:
The market is segmented by PerfOs (Performance Outcomes), by Application (Clinical Trial SponsorsContract Research Organizations (Contract Research Organizations CROs, Clinical Trial Sponsors), by Solution Type (eCOA (eCOA Electronic Clinical Outcome Assessments), by ObsROs (Observer Reported Outcomes), by ClinROs (Clinician Reported Outcomes), by EPROs (Patient Reported Outcomes), by Modality Type (Computer Mobile Devices (Tablets, Mobile Devices Smartphones, Computer).
ePRO, e-Patient Diaries and eCOA Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the ePRO, e-Patient Diaries and eCOA Market
Overview of the regional outlook of the ePRO, e-Patient Diaries and eCOA Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The ePRO, e-Patient Diaries and eCOA Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of ePRO, e-Patient Diaries and eCOA Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Performance Outcomes
7. By Application (Clinical Trial SponsorsContract Research Organizations:1. Contract Research Organizations CROs
2. Clinical Trial Sponsors
8. By Solution Type (eCOA:1. eCOA Electronic Clinical Outcome Assessments
9. By ObsROs:1. Observer Reported Outcomes
10. By ClinROs:1. Clinician Reported Outcomes
11. By EPROs:1. Patient Reported Outcomes
12. By Modality Type (Computer Mobile Devices:1. Tablets
2. Mobile Devices Smartphones
3. Computer
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the ePRO, e-Patient Diaries and eCOA Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the ePRO, e-Patient Diaries and eCOA Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 ePRO, e-Patient Diaries and eCOA Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 ePRO, e-Patient Diaries and eCOA Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 ePRO, e-Patient Diaries and eCOA Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the ePRO, e-Patient Diaries and eCOA Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global ePRO, e-Patient Diaries and eCOA Market Size & Forecast, 2018-2028
4.5.1 ePRO, e-Patient Diaries and eCOA Market Size and Y-o-Y Growth
4.5.2 ePRO, e-Patient Diaries and eCOA Market Absolute $ Opportunity
Chapter 5 Global ePRO, e-Patient Diaries and eCOA Market Analysis and Forecast by PerfOs
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by PerfOs
5.1.2 Basis Point Share (BPS) Analysis by PerfOs
5.1.3 Absolute $ Opportunity Assessment by PerfOs
5.2 ePRO, e-Patient Diaries and eCOA Market Size Forecast by PerfOs
5.2.1 Performance Outcomes
5.3 Market Attractiveness Analysis by PerfOs
Chapter 6 Global ePRO, e-Patient Diaries and eCOA Market Analysis and Forecast by Application (Clinical Trial SponsorsContract Research Organizations
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Application (Clinical Trial SponsorsContract Research Organizations
6.1.2 Basis Point Share (BPS) Analysis by Application (Clinical Trial SponsorsContract Research Organizations
6.1.3 Absolute $ Opportunity Assessment by Application (Clinical Trial SponsorsContract Research Organizations
6.2 ePRO, e-Patient Diaries and eCOA Market Size Forecast by Application (Clinical Trial SponsorsContract Research Organizations
6.2.1 Contract Research Organizations CROs
6.2.2 Clinical Trial Sponsors
6.3 Market Attractiveness Analysis by Application (Clinical Trial SponsorsContract Research Organizations
Chapter 7 Global ePRO, e-Patient Diaries and eCOA Market Analysis and Forecast by Solution Type (eCOA
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Solution Type (eCOA
7.1.2 Basis Point Share (BPS) Analysis by Solution Type (eCOA
7.1.3 Absolute $ Opportunity Assessment by Solution Type (eCOA
7.2 ePRO, e-Patient Diaries and eCOA Market Size Forecast by Solution Type (eCOA
7.2.1 eCOA Electronic Clinical Outcome Assessments
7.3 Market Attractiveness Analysis by Solution Type (eCOA
Chapter 8 Global ePRO, e-Patient Diaries and eCOA Market Analysis and Forecast by ObsROs
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by ObsROs
8.1.2 Basis Point Share (BPS) Analysis by ObsROs
8.1.3 Absolute $ Opportunity Assessment by ObsROs
8.2 ePRO, e-Patient Diaries and eCOA Market Size Forecast by ObsROs
8.2.1 Observer Reported Outcomes
8.3 Market Attractiveness Analysis by ObsROs
Chapter 9 Global ePRO, e-Patient Diaries and eCOA Market Analysis and Forecast by ClinROs
9.1 Introduction
9.1.1 Key Market Trends & Growth Opportunities by ClinROs
9.1.2 Basis Point Share (BPS) Analysis by ClinROs
9.1.3 Absolute $ Opportunity Assessment by ClinROs
9.2 ePRO, e-Patient Diaries and eCOA Market Size Forecast by ClinROs
9.2.1 Clinician Reported Outcomes
9.3 Market Attractiveness Analysis by ClinROs
Chapter 10 Global ePRO, e-Patient Diaries and eCOA Market Analysis and Forecast by EPROs
10.1 Introduction
10.1.1 Key Market Trends & Growth Opportunities by EPROs
10.1.2 Basis Point Share (BPS) Analysis by EPROs
10.1.3 Absolute $ Opportunity Assessment by EPROs
10.2 ePRO, e-Patient Diaries and eCOA Market Size Forecast by EPROs
10.2.1 Patient Reported Outcomes
10.3 Market Attractiveness Analysis by EPROs
Chapter 11 Global ePRO, e-Patient Diaries and eCOA Market Analysis and Forecast by Modality Type (Computer Mobile Devices
11.1 Introduction
11.1.1 Key Market Trends & Growth Opportunities by Modality Type (Computer Mobile Devices
11.1.2 Basis Point Share (BPS) Analysis by Modality Type (Computer Mobile Devices
11.1.3 Absolute $ Opportunity Assessment by Modality Type (Computer Mobile Devices
11.2 ePRO, e-Patient Diaries and eCOA Market Size Forecast by Modality Type (Computer Mobile Devices
11.2.1 Tablets
11.2.2 Mobile Devices Smartphones
11.2.3 Computer
11.3 Market Attractiveness Analysis by Modality Type (Computer Mobile Devices
Chapter 12 Global ePRO, e-Patient Diaries and eCOA Market Analysis and Forecast by Region
12.1 Introduction
12.1.1 Key Market Trends & Growth Opportunities by Region
12.1.2 Basis Point Share (BPS) Analysis by Region
12.1.3 Absolute $ Opportunity Assessment by Region
12.2 ePRO, e-Patient Diaries and eCOA Market Size Forecast by Region
12.2.1 North America
12.2.2 Europe
12.2.3 Asia Pacific
12.2.4 Latin America
12.2.5 Middle East & Africa (MEA)
12.3 Market Attractiveness Analysis by Region
Chapter 13 Coronavirus Disease (COVID-19) Impact
13.1 Introduction
13.2 Current & Future Impact Analysis
13.3 Economic Impact Analysis
13.4 Government Policies
13.5 Investment Scenario
Chapter 14 North America ePRO, e-Patient Diaries and eCOA Analysis and Forecast
14.1 Introduction
14.2 North America ePRO, e-Patient Diaries and eCOA Market Size Forecast by Country
14.2.1 U.S.
14.2.2 Canada
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 North America ePRO, e-Patient Diaries and eCOA Market Size Forecast by PerfOs
14.6.1 Performance Outcomes
14.7 Basis Point Share (BPS) Analysis by PerfOs
14.8 Absolute $ Opportunity Assessment by PerfOs
14.9 Market Attractiveness Analysis by PerfOs
14.10 North America ePRO, e-Patient Diaries and eCOA Market Size Forecast by Application (Clinical Trial SponsorsContract Research Organizations
14.10.1 Contract Research Organizations CROs
14.10.2 Clinical Trial Sponsors
14.11 Basis Point Share (BPS) Analysis by Application (Clinical Trial SponsorsContract Research Organizations
14.12 Absolute $ Opportunity Assessment by Application (Clinical Trial SponsorsContract Research Organizations
14.13 Market Attractiveness Analysis by Application (Clinical Trial SponsorsContract Research Organizations
14.14 North America ePRO, e-Patient Diaries and eCOA Market Size Forecast by Solution Type (eCOA
14.14.1 eCOA Electronic Clinical Outcome Assessments
14.15 Basis Point Share (BPS) Analysis by Solution Type (eCOA
14.16 Absolute $ Opportunity Assessment by Solution Type (eCOA
14.17 Market Attractiveness Analysis by Solution Type (eCOA
14.18 North America ePRO, e-Patient Diaries and eCOA Market Size Forecast by ObsROs
14.18.1 Observer Reported Outcomes
14.19 Basis Point Share (BPS) Analysis by ObsROs
14.20 Absolute $ Opportunity Assessment by ObsROs
14.21 Market Attractiveness Analysis by ObsROs
14.22 North America ePRO, e-Patient Diaries and eCOA Market Size Forecast by ClinROs
14.22.1 Clinician Reported Outcomes
14.23 Basis Point Share (BPS) Analysis by ClinROs
14.24 Absolute $ Opportunity Assessment by ClinROs
14.25 Market Attractiveness Analysis by ClinROs
14.26 North America ePRO, e-Patient Diaries and eCOA Market Size Forecast by EPROs
14.26.1 Patient Reported Outcomes
14.27 Basis Point Share (BPS) Analysis by EPROs
14.28 Absolute $ Opportunity Assessment by EPROs
14.29 Market Attractiveness Analysis by EPROs
14.30 North America ePRO, e-Patient Diaries and eCOA Market Size Forecast by Modality Type (Computer Mobile Devices
14.30.1 Tablets
14.30.2 Mobile Devices Smartphones
14.30.3 Computer
14.31 Basis Point Share (BPS) Analysis by Modality Type (Computer Mobile Devices
14.32 Absolute $ Opportunity Assessment by Modality Type (Computer Mobile Devices
14.33 Market Attractiveness Analysis by Modality Type (Computer Mobile Devices
Chapter 15 Europe ePRO, e-Patient Diaries and eCOA Analysis and Forecast
15.1 Introduction
15.2 Europe ePRO, e-Patient Diaries and eCOA Market Size Forecast by Country
15.2.1 Germany
15.2.2 France
15.2.3 Italy
15.2.4 U.K.
15.2.5 Spain
15.2.6 Russia
15.2.7 Rest of Europe
15.3 Basis Point Share (BPS) Analysis by Country
15.4 Absolute $ Opportunity Assessment by Country
15.5 Market Attractiveness Analysis by Country
15.6 Europe ePRO, e-Patient Diaries and eCOA Market Size Forecast by PerfOs
15.6.1 Performance Outcomes
15.7 Basis Point Share (BPS) Analysis by PerfOs
15.8 Absolute $ Opportunity Assessment by PerfOs
15.9 Market Attractiveness Analysis by PerfOs
15.10 Europe ePRO, e-Patient Diaries and eCOA Market Size Forecast by Application (Clinical Trial SponsorsContract Research Organizations
15.10.1 Contract Research Organizations CROs
15.10.2 Clinical Trial Sponsors
15.11 Basis Point Share (BPS) Analysis by Application (Clinical Trial SponsorsContract Research Organizations
15.12 Absolute $ Opportunity Assessment by Application (Clinical Trial SponsorsContract Research Organizations
15.13 Market Attractiveness Analysis by Application (Clinical Trial SponsorsContract Research Organizations
15.14 Europe ePRO, e-Patient Diaries and eCOA Market Size Forecast by Solution Type (eCOA
15.14.1 eCOA Electronic Clinical Outcome Assessments
15.15 Basis Point Share (BPS) Analysis by Solution Type (eCOA
15.16 Absolute $ Opportunity Assessment by Solution Type (eCOA
15.17 Market Attractiveness Analysis by Solution Type (eCOA
15.18 Europe ePRO, e-Patient Diaries and eCOA Market Size Forecast by ObsROs
15.18.1 Observer Reported Outcomes
15.19 Basis Point Share (BPS) Analysis by ObsROs
15.20 Absolute $ Opportunity Assessment by ObsROs
15.21 Market Attractiveness Analysis by ObsROs
15.22 Europe ePRO, e-Patient Diaries and eCOA Market Size Forecast by ClinROs
15.22.1 Clinician Reported Outcomes
15.23 Basis Point Share (BPS) Analysis by ClinROs
15.24 Absolute $ Opportunity Assessment by ClinROs
15.25 Market Attractiveness Analysis by ClinROs
15.26 Europe ePRO, e-Patient Diaries and eCOA Market Size Forecast by EPROs
15.26.1 Patient Reported Outcomes
15.27 Basis Point Share (BPS) Analysis by EPROs
15.28 Absolute $ Opportunity Assessment by EPROs
15.29 Market Attractiveness Analysis by EPROs
15.30 Europe ePRO, e-Patient Diaries and eCOA Market Size Forecast by Modality Type (Computer Mobile Devices
15.30.1 Tablets
15.30.2 Mobile Devices Smartphones
15.30.3 Computer
15.31 Basis Point Share (BPS) Analysis by Modality Type (Computer Mobile Devices
15.32 Absolute $ Opportunity Assessment by Modality Type (Computer Mobile Devices
15.33 Market Attractiveness Analysis by Modality Type (Computer Mobile Devices
Chapter 16 Asia Pacific ePRO, e-Patient Diaries and eCOA Analysis and Forecast
16.1 Introduction
16.2 Asia Pacific ePRO, e-Patient Diaries and eCOA Market Size Forecast by Country
16.2.1 China
16.2.2 Japan
16.2.3 South Korea
16.2.4 India
16.2.5 Australia
16.2.6 South East Asia (SEA)
16.2.7 Rest of Asia Pacific (APAC)
16.3 Basis Point Share (BPS) Analysis by Country
16.4 Absolute $ Opportunity Assessment by Country
16.5 Market Attractiveness Analysis by Country
16.6 Asia Pacific ePRO, e-Patient Diaries and eCOA Market Size Forecast by PerfOs
16.6.1 Performance Outcomes
16.7 Basis Point Share (BPS) Analysis by PerfOs
16.8 Absolute $ Opportunity Assessment by PerfOs
16.9 Market Attractiveness Analysis by PerfOs
16.10 Asia Pacific ePRO, e-Patient Diaries and eCOA Market Size Forecast by Application (Clinical Trial SponsorsContract Research Organizations
16.10.1 Contract Research Organizations CROs
16.10.2 Clinical Trial Sponsors
16.11 Basis Point Share (BPS) Analysis by Application (Clinical Trial SponsorsContract Research Organizations
16.12 Absolute $ Opportunity Assessment by Application (Clinical Trial SponsorsContract Research Organizations
16.13 Market Attractiveness Analysis by Application (Clinical Trial SponsorsContract Research Organizations
16.14 Asia Pacific ePRO, e-Patient Diaries and eCOA Market Size Forecast by Solution Type (eCOA
16.14.1 eCOA Electronic Clinical Outcome Assessments
16.15 Basis Point Share (BPS) Analysis by Solution Type (eCOA
16.16 Absolute $ Opportunity Assessment by Solution Type (eCOA
16.17 Market Attractiveness Analysis by Solution Type (eCOA
16.18 Asia Pacific ePRO, e-Patient Diaries and eCOA Market Size Forecast by ObsROs
16.18.1 Observer Reported Outcomes
16.19 Basis Point Share (BPS) Analysis by ObsROs
16.20 Absolute $ Opportunity Assessment by ObsROs
16.21 Market Attractiveness Analysis by ObsROs
16.22 Asia Pacific ePRO, e-Patient Diaries and eCOA Market Size Forecast by ClinROs
16.22.1 Clinician Reported Outcomes
16.23 Basis Point Share (BPS) Analysis by ClinROs
16.24 Absolute $ Opportunity Assessment by ClinROs
16.25 Market Attractiveness Analysis by ClinROs
16.26 Asia Pacific ePRO, e-Patient Diaries and eCOA Market Size Forecast by EPROs
16.26.1 Patient Reported Outcomes
16.27 Basis Point Share (BPS) Analysis by EPROs
16.28 Absolute $ Opportunity Assessment by EPROs
16.29 Market Attractiveness Analysis by EPROs
16.30 Asia Pacific ePRO, e-Patient Diaries and eCOA Market Size Forecast by Modality Type (Computer Mobile Devices
16.30.1 Tablets
16.30.2 Mobile Devices Smartphones
16.30.3 Computer
16.31 Basis Point Share (BPS) Analysis by Modality Type (Computer Mobile Devices
16.32 Absolute $ Opportunity Assessment by Modality Type (Computer Mobile Devices
16.33 Market Attractiveness Analysis by Modality Type (Computer Mobile Devices
Chapter 17 Latin America ePRO, e-Patient Diaries and eCOA Analysis and Forecast
17.1 Introduction
17.2 Latin America ePRO, e-Patient Diaries and eCOA Market Size Forecast by Country
17.2.1 Brazil
17.2.2 Mexico
17.2.3 Rest of Latin America (LATAM)
17.3 Basis Point Share (BPS) Analysis by Country
17.4 Absolute $ Opportunity Assessment by Country
17.5 Market Attractiveness Analysis by Country
17.6 Latin America ePRO, e-Patient Diaries and eCOA Market Size Forecast by PerfOs
17.6.1 Performance Outcomes
17.7 Basis Point Share (BPS) Analysis by PerfOs
17.8 Absolute $ Opportunity Assessment by PerfOs
17.9 Market Attractiveness Analysis by PerfOs
17.10 Latin America ePRO, e-Patient Diaries and eCOA Market Size Forecast by Application (Clinical Trial SponsorsContract Research Organizations
17.10.1 Contract Research Organizations CROs
17.10.2 Clinical Trial Sponsors
17.11 Basis Point Share (BPS) Analysis by Application (Clinical Trial SponsorsContract Research Organizations
17.12 Absolute $ Opportunity Assessment by Application (Clinical Trial SponsorsContract Research Organizations
17.13 Market Attractiveness Analysis by Application (Clinical Trial SponsorsContract Research Organizations
17.14 Latin America ePRO, e-Patient Diaries and eCOA Market Size Forecast by Solution Type (eCOA
17.14.1 eCOA Electronic Clinical Outcome Assessments
17.15 Basis Point Share (BPS) Analysis by Solution Type (eCOA
17.16 Absolute $ Opportunity Assessment by Solution Type (eCOA
17.17 Market Attractiveness Analysis by Solution Type (eCOA
17.18 Latin America ePRO, e-Patient Diaries and eCOA Market Size Forecast by ObsROs
17.18.1 Observer Reported Outcomes
17.19 Basis Point Share (BPS) Analysis by ObsROs
17.20 Absolute $ Opportunity Assessment by ObsROs
17.21 Market Attractiveness Analysis by ObsROs
17.22 Latin America ePRO, e-Patient Diaries and eCOA Market Size Forecast by ClinROs
17.22.1 Clinician Reported Outcomes
17.23 Basis Point Share (BPS) Analysis by ClinROs
17.24 Absolute $ Opportunity Assessment by ClinROs
17.25 Market Attractiveness Analysis by ClinROs
17.26 Latin America ePRO, e-Patient Diaries and eCOA Market Size Forecast by EPROs
17.26.1 Patient Reported Outcomes
17.27 Basis Point Share (BPS) Analysis by EPROs
17.28 Absolute $ Opportunity Assessment by EPROs
17.29 Market Attractiveness Analysis by EPROs
17.30 Latin America ePRO, e-Patient Diaries and eCOA Market Size Forecast by Modality Type (Computer Mobile Devices
17.30.1 Tablets
17.30.2 Mobile Devices Smartphones
17.30.3 Computer
17.31 Basis Point Share (BPS) Analysis by Modality Type (Computer Mobile Devices
17.32 Absolute $ Opportunity Assessment by Modality Type (Computer Mobile Devices
17.33 Market Attractiveness Analysis by Modality Type (Computer Mobile Devices
Chapter 18 Middle East & Africa (MEA) ePRO, e-Patient Diaries and eCOA Analysis and Forecast
18.1 Introduction
18.2 Middle East & Africa (MEA) ePRO, e-Patient Diaries and eCOA Market Size Forecast by Country
18.2.1 Saudi Arabia
18.2.2 South Africa
18.2.3 UAE
18.2.4 Rest of Middle East & Africa (MEA)
18.3 Basis Point Share (BPS) Analysis by Country
18.4 Absolute $ Opportunity Assessment by Country
18.5 Market Attractiveness Analysis by Country
18.6 Middle East & Africa (MEA) ePRO, e-Patient Diaries and eCOA Market Size Forecast by PerfOs
18.6.1 Performance Outcomes
18.7 Basis Point Share (BPS) Analysis by PerfOs
18.8 Absolute $ Opportunity Assessment by PerfOs
18.9 Market Attractiveness Analysis by PerfOs
18.10 Middle East & Africa (MEA) ePRO, e-Patient Diaries and eCOA Market Size Forecast by Application (Clinical Trial SponsorsContract Research Organizations
18.10.1 Contract Research Organizations CROs
18.10.2 Clinical Trial Sponsors
18.11 Basis Point Share (BPS) Analysis by Application (Clinical Trial SponsorsContract Research Organizations
18.12 Absolute $ Opportunity Assessment by Application (Clinical Trial SponsorsContract Research Organizations
18.13 Market Attractiveness Analysis by Application (Clinical Trial SponsorsContract Research Organizations
18.14 Middle East & Africa (MEA) ePRO, e-Patient Diaries and eCOA Market Size Forecast by Solution Type (eCOA
18.14.1 eCOA Electronic Clinical Outcome Assessments
18.15 Basis Point Share (BPS) Analysis by Solution Type (eCOA
18.16 Absolute $ Opportunity Assessment by Solution Type (eCOA
18.17 Market Attractiveness Analysis by Solution Type (eCOA
18.18 Middle East & Africa (MEA) ePRO, e-Patient Diaries and eCOA Market Size Forecast by ObsROs
18.18.1 Observer Reported Outcomes
18.19 Basis Point Share (BPS) Analysis by ObsROs
18.20 Absolute $ Opportunity Assessment by ObsROs
18.21 Market Attractiveness Analysis by ObsROs
18.22 Middle East & Africa (MEA) ePRO, e-Patient Diaries and eCOA Market Size Forecast by ClinROs
18.22.1 Clinician Reported Outcomes
18.23 Basis Point Share (BPS) Analysis by ClinROs
18.24 Absolute $ Opportunity Assessment by ClinROs
18.25 Market Attractiveness Analysis by ClinROs
18.26 Middle East & Africa (MEA) ePRO, e-Patient Diaries and eCOA Market Size Forecast by EPROs
18.26.1 Patient Reported Outcomes
18.27 Basis Point Share (BPS) Analysis by EPROs
18.28 Absolute $ Opportunity Assessment by EPROs
18.29 Market Attractiveness Analysis by EPROs
18.30 Middle East & Africa (MEA) ePRO, e-Patient Diaries and eCOA Market Size Forecast by Modality Type (Computer Mobile Devices
18.30.1 Tablets
18.30.2 Mobile Devices Smartphones
18.30.3 Computer
18.31 Basis Point Share (BPS) Analysis by Modality Type (Computer Mobile Devices
18.32 Absolute $ Opportunity Assessment by Modality Type (Computer Mobile Devices
18.33 Market Attractiveness Analysis by Modality Type (Computer Mobile Devices
Chapter 19 Competition Landscape
19.1 ePRO, e-Patient Diaries and eCOA Market: Competitive Dashboard
19.2 Global ePRO, e-Patient Diaries and eCOA Market: Market Share Analysis, 2019
19.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
19.3.1 Medidata Solutions Inc.
19.3.2 ERT Clinical
19.3.3 Health Diary Inc.
19.3.4 PAREXEL International Corporation
19.3.5 OmniComm Systems Inc.
19.3.6 Major players analyzed include Bracket Global LLC
19.3.7 SAS
19.3.8 Kayentis
19.3.9 ICON plc
19.3.10 Others.
19.3.11 ArisGlobal LLC
19.3.12 CRF Health Inc.
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 ePRO, e-Patient Diaries and eCOA Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 ePRO, e-Patient Diaries and eCOA Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 ePRO, e-Patient Diaries and eCOA Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the ePRO, e-Patient Diaries and eCOA Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global ePRO, e-Patient Diaries and eCOA Market Size & Forecast, 2018-2028
4.5.1 ePRO, e-Patient Diaries and eCOA Market Size and Y-o-Y Growth
4.5.2 ePRO, e-Patient Diaries and eCOA Market Absolute $ Opportunity
Chapter 5 Global ePRO, e-Patient Diaries and eCOA Market Analysis and Forecast by PerfOs
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by PerfOs
5.1.2 Basis Point Share (BPS) Analysis by PerfOs
5.1.3 Absolute $ Opportunity Assessment by PerfOs
5.2 ePRO, e-Patient Diaries and eCOA Market Size Forecast by PerfOs
5.2.1 Performance Outcomes
5.3 Market Attractiveness Analysis by PerfOs
Chapter 6 Global ePRO, e-Patient Diaries and eCOA Market Analysis and Forecast by Application (Clinical Trial SponsorsContract Research Organizations
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Application (Clinical Trial SponsorsContract Research Organizations
6.1.2 Basis Point Share (BPS) Analysis by Application (Clinical Trial SponsorsContract Research Organizations
6.1.3 Absolute $ Opportunity Assessment by Application (Clinical Trial SponsorsContract Research Organizations
6.2 ePRO, e-Patient Diaries and eCOA Market Size Forecast by Application (Clinical Trial SponsorsContract Research Organizations
6.2.1 Contract Research Organizations CROs
6.2.2 Clinical Trial Sponsors
6.3 Market Attractiveness Analysis by Application (Clinical Trial SponsorsContract Research Organizations
Chapter 7 Global ePRO, e-Patient Diaries and eCOA Market Analysis and Forecast by Solution Type (eCOA
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Solution Type (eCOA
7.1.2 Basis Point Share (BPS) Analysis by Solution Type (eCOA
7.1.3 Absolute $ Opportunity Assessment by Solution Type (eCOA
7.2 ePRO, e-Patient Diaries and eCOA Market Size Forecast by Solution Type (eCOA
7.2.1 eCOA Electronic Clinical Outcome Assessments
7.3 Market Attractiveness Analysis by Solution Type (eCOA
Chapter 8 Global ePRO, e-Patient Diaries and eCOA Market Analysis and Forecast by ObsROs
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by ObsROs
8.1.2 Basis Point Share (BPS) Analysis by ObsROs
8.1.3 Absolute $ Opportunity Assessment by ObsROs
8.2 ePRO, e-Patient Diaries and eCOA Market Size Forecast by ObsROs
8.2.1 Observer Reported Outcomes
8.3 Market Attractiveness Analysis by ObsROs
Chapter 9 Global ePRO, e-Patient Diaries and eCOA Market Analysis and Forecast by ClinROs
9.1 Introduction
9.1.1 Key Market Trends & Growth Opportunities by ClinROs
9.1.2 Basis Point Share (BPS) Analysis by ClinROs
9.1.3 Absolute $ Opportunity Assessment by ClinROs
9.2 ePRO, e-Patient Diaries and eCOA Market Size Forecast by ClinROs
9.2.1 Clinician Reported Outcomes
9.3 Market Attractiveness Analysis by ClinROs
Chapter 10 Global ePRO, e-Patient Diaries and eCOA Market Analysis and Forecast by EPROs
10.1 Introduction
10.1.1 Key Market Trends & Growth Opportunities by EPROs
10.1.2 Basis Point Share (BPS) Analysis by EPROs
10.1.3 Absolute $ Opportunity Assessment by EPROs
10.2 ePRO, e-Patient Diaries and eCOA Market Size Forecast by EPROs
10.2.1 Patient Reported Outcomes
10.3 Market Attractiveness Analysis by EPROs
Chapter 11 Global ePRO, e-Patient Diaries and eCOA Market Analysis and Forecast by Modality Type (Computer Mobile Devices
11.1 Introduction
11.1.1 Key Market Trends & Growth Opportunities by Modality Type (Computer Mobile Devices
11.1.2 Basis Point Share (BPS) Analysis by Modality Type (Computer Mobile Devices
11.1.3 Absolute $ Opportunity Assessment by Modality Type (Computer Mobile Devices
11.2 ePRO, e-Patient Diaries and eCOA Market Size Forecast by Modality Type (Computer Mobile Devices
11.2.1 Tablets
11.2.2 Mobile Devices Smartphones
11.2.3 Computer
11.3 Market Attractiveness Analysis by Modality Type (Computer Mobile Devices
Chapter 12 Global ePRO, e-Patient Diaries and eCOA Market Analysis and Forecast by Region
12.1 Introduction
12.1.1 Key Market Trends & Growth Opportunities by Region
12.1.2 Basis Point Share (BPS) Analysis by Region
12.1.3 Absolute $ Opportunity Assessment by Region
12.2 ePRO, e-Patient Diaries and eCOA Market Size Forecast by Region
12.2.1 North America
12.2.2 Europe
12.2.3 Asia Pacific
12.2.4 Latin America
12.2.5 Middle East & Africa (MEA)
12.3 Market Attractiveness Analysis by Region
Chapter 13 Coronavirus Disease (COVID-19) Impact
13.1 Introduction
13.2 Current & Future Impact Analysis
13.3 Economic Impact Analysis
13.4 Government Policies
13.5 Investment Scenario
Chapter 14 North America ePRO, e-Patient Diaries and eCOA Analysis and Forecast
14.1 Introduction
14.2 North America ePRO, e-Patient Diaries and eCOA Market Size Forecast by Country
14.2.1 U.S.
14.2.2 Canada
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 North America ePRO, e-Patient Diaries and eCOA Market Size Forecast by PerfOs
14.6.1 Performance Outcomes
14.7 Basis Point Share (BPS) Analysis by PerfOs
14.8 Absolute $ Opportunity Assessment by PerfOs
14.9 Market Attractiveness Analysis by PerfOs
14.10 North America ePRO, e-Patient Diaries and eCOA Market Size Forecast by Application (Clinical Trial SponsorsContract Research Organizations
14.10.1 Contract Research Organizations CROs
14.10.2 Clinical Trial Sponsors
14.11 Basis Point Share (BPS) Analysis by Application (Clinical Trial SponsorsContract Research Organizations
14.12 Absolute $ Opportunity Assessment by Application (Clinical Trial SponsorsContract Research Organizations
14.13 Market Attractiveness Analysis by Application (Clinical Trial SponsorsContract Research Organizations
14.14 North America ePRO, e-Patient Diaries and eCOA Market Size Forecast by Solution Type (eCOA
14.14.1 eCOA Electronic Clinical Outcome Assessments
14.15 Basis Point Share (BPS) Analysis by Solution Type (eCOA
14.16 Absolute $ Opportunity Assessment by Solution Type (eCOA
14.17 Market Attractiveness Analysis by Solution Type (eCOA
14.18 North America ePRO, e-Patient Diaries and eCOA Market Size Forecast by ObsROs
14.18.1 Observer Reported Outcomes
14.19 Basis Point Share (BPS) Analysis by ObsROs
14.20 Absolute $ Opportunity Assessment by ObsROs
14.21 Market Attractiveness Analysis by ObsROs
14.22 North America ePRO, e-Patient Diaries and eCOA Market Size Forecast by ClinROs
14.22.1 Clinician Reported Outcomes
14.23 Basis Point Share (BPS) Analysis by ClinROs
14.24 Absolute $ Opportunity Assessment by ClinROs
14.25 Market Attractiveness Analysis by ClinROs
14.26 North America ePRO, e-Patient Diaries and eCOA Market Size Forecast by EPROs
14.26.1 Patient Reported Outcomes
14.27 Basis Point Share (BPS) Analysis by EPROs
14.28 Absolute $ Opportunity Assessment by EPROs
14.29 Market Attractiveness Analysis by EPROs
14.30 North America ePRO, e-Patient Diaries and eCOA Market Size Forecast by Modality Type (Computer Mobile Devices
14.30.1 Tablets
14.30.2 Mobile Devices Smartphones
14.30.3 Computer
14.31 Basis Point Share (BPS) Analysis by Modality Type (Computer Mobile Devices
14.32 Absolute $ Opportunity Assessment by Modality Type (Computer Mobile Devices
14.33 Market Attractiveness Analysis by Modality Type (Computer Mobile Devices
Chapter 15 Europe ePRO, e-Patient Diaries and eCOA Analysis and Forecast
15.1 Introduction
15.2 Europe ePRO, e-Patient Diaries and eCOA Market Size Forecast by Country
15.2.1 Germany
15.2.2 France
15.2.3 Italy
15.2.4 U.K.
15.2.5 Spain
15.2.6 Russia
15.2.7 Rest of Europe
15.3 Basis Point Share (BPS) Analysis by Country
15.4 Absolute $ Opportunity Assessment by Country
15.5 Market Attractiveness Analysis by Country
15.6 Europe ePRO, e-Patient Diaries and eCOA Market Size Forecast by PerfOs
15.6.1 Performance Outcomes
15.7 Basis Point Share (BPS) Analysis by PerfOs
15.8 Absolute $ Opportunity Assessment by PerfOs
15.9 Market Attractiveness Analysis by PerfOs
15.10 Europe ePRO, e-Patient Diaries and eCOA Market Size Forecast by Application (Clinical Trial SponsorsContract Research Organizations
15.10.1 Contract Research Organizations CROs
15.10.2 Clinical Trial Sponsors
15.11 Basis Point Share (BPS) Analysis by Application (Clinical Trial SponsorsContract Research Organizations
15.12 Absolute $ Opportunity Assessment by Application (Clinical Trial SponsorsContract Research Organizations
15.13 Market Attractiveness Analysis by Application (Clinical Trial SponsorsContract Research Organizations
15.14 Europe ePRO, e-Patient Diaries and eCOA Market Size Forecast by Solution Type (eCOA
15.14.1 eCOA Electronic Clinical Outcome Assessments
15.15 Basis Point Share (BPS) Analysis by Solution Type (eCOA
15.16 Absolute $ Opportunity Assessment by Solution Type (eCOA
15.17 Market Attractiveness Analysis by Solution Type (eCOA
15.18 Europe ePRO, e-Patient Diaries and eCOA Market Size Forecast by ObsROs
15.18.1 Observer Reported Outcomes
15.19 Basis Point Share (BPS) Analysis by ObsROs
15.20 Absolute $ Opportunity Assessment by ObsROs
15.21 Market Attractiveness Analysis by ObsROs
15.22 Europe ePRO, e-Patient Diaries and eCOA Market Size Forecast by ClinROs
15.22.1 Clinician Reported Outcomes
15.23 Basis Point Share (BPS) Analysis by ClinROs
15.24 Absolute $ Opportunity Assessment by ClinROs
15.25 Market Attractiveness Analysis by ClinROs
15.26 Europe ePRO, e-Patient Diaries and eCOA Market Size Forecast by EPROs
15.26.1 Patient Reported Outcomes
15.27 Basis Point Share (BPS) Analysis by EPROs
15.28 Absolute $ Opportunity Assessment by EPROs
15.29 Market Attractiveness Analysis by EPROs
15.30 Europe ePRO, e-Patient Diaries and eCOA Market Size Forecast by Modality Type (Computer Mobile Devices
15.30.1 Tablets
15.30.2 Mobile Devices Smartphones
15.30.3 Computer
15.31 Basis Point Share (BPS) Analysis by Modality Type (Computer Mobile Devices
15.32 Absolute $ Opportunity Assessment by Modality Type (Computer Mobile Devices
15.33 Market Attractiveness Analysis by Modality Type (Computer Mobile Devices
Chapter 16 Asia Pacific ePRO, e-Patient Diaries and eCOA Analysis and Forecast
16.1 Introduction
16.2 Asia Pacific ePRO, e-Patient Diaries and eCOA Market Size Forecast by Country
16.2.1 China
16.2.2 Japan
16.2.3 South Korea
16.2.4 India
16.2.5 Australia
16.2.6 South East Asia (SEA)
16.2.7 Rest of Asia Pacific (APAC)
16.3 Basis Point Share (BPS) Analysis by Country
16.4 Absolute $ Opportunity Assessment by Country
16.5 Market Attractiveness Analysis by Country
16.6 Asia Pacific ePRO, e-Patient Diaries and eCOA Market Size Forecast by PerfOs
16.6.1 Performance Outcomes
16.7 Basis Point Share (BPS) Analysis by PerfOs
16.8 Absolute $ Opportunity Assessment by PerfOs
16.9 Market Attractiveness Analysis by PerfOs
16.10 Asia Pacific ePRO, e-Patient Diaries and eCOA Market Size Forecast by Application (Clinical Trial SponsorsContract Research Organizations
16.10.1 Contract Research Organizations CROs
16.10.2 Clinical Trial Sponsors
16.11 Basis Point Share (BPS) Analysis by Application (Clinical Trial SponsorsContract Research Organizations
16.12 Absolute $ Opportunity Assessment by Application (Clinical Trial SponsorsContract Research Organizations
16.13 Market Attractiveness Analysis by Application (Clinical Trial SponsorsContract Research Organizations
16.14 Asia Pacific ePRO, e-Patient Diaries and eCOA Market Size Forecast by Solution Type (eCOA
16.14.1 eCOA Electronic Clinical Outcome Assessments
16.15 Basis Point Share (BPS) Analysis by Solution Type (eCOA
16.16 Absolute $ Opportunity Assessment by Solution Type (eCOA
16.17 Market Attractiveness Analysis by Solution Type (eCOA
16.18 Asia Pacific ePRO, e-Patient Diaries and eCOA Market Size Forecast by ObsROs
16.18.1 Observer Reported Outcomes
16.19 Basis Point Share (BPS) Analysis by ObsROs
16.20 Absolute $ Opportunity Assessment by ObsROs
16.21 Market Attractiveness Analysis by ObsROs
16.22 Asia Pacific ePRO, e-Patient Diaries and eCOA Market Size Forecast by ClinROs
16.22.1 Clinician Reported Outcomes
16.23 Basis Point Share (BPS) Analysis by ClinROs
16.24 Absolute $ Opportunity Assessment by ClinROs
16.25 Market Attractiveness Analysis by ClinROs
16.26 Asia Pacific ePRO, e-Patient Diaries and eCOA Market Size Forecast by EPROs
16.26.1 Patient Reported Outcomes
16.27 Basis Point Share (BPS) Analysis by EPROs
16.28 Absolute $ Opportunity Assessment by EPROs
16.29 Market Attractiveness Analysis by EPROs
16.30 Asia Pacific ePRO, e-Patient Diaries and eCOA Market Size Forecast by Modality Type (Computer Mobile Devices
16.30.1 Tablets
16.30.2 Mobile Devices Smartphones
16.30.3 Computer
16.31 Basis Point Share (BPS) Analysis by Modality Type (Computer Mobile Devices
16.32 Absolute $ Opportunity Assessment by Modality Type (Computer Mobile Devices
16.33 Market Attractiveness Analysis by Modality Type (Computer Mobile Devices
Chapter 17 Latin America ePRO, e-Patient Diaries and eCOA Analysis and Forecast
17.1 Introduction
17.2 Latin America ePRO, e-Patient Diaries and eCOA Market Size Forecast by Country
17.2.1 Brazil
17.2.2 Mexico
17.2.3 Rest of Latin America (LATAM)
17.3 Basis Point Share (BPS) Analysis by Country
17.4 Absolute $ Opportunity Assessment by Country
17.5 Market Attractiveness Analysis by Country
17.6 Latin America ePRO, e-Patient Diaries and eCOA Market Size Forecast by PerfOs
17.6.1 Performance Outcomes
17.7 Basis Point Share (BPS) Analysis by PerfOs
17.8 Absolute $ Opportunity Assessment by PerfOs
17.9 Market Attractiveness Analysis by PerfOs
17.10 Latin America ePRO, e-Patient Diaries and eCOA Market Size Forecast by Application (Clinical Trial SponsorsContract Research Organizations
17.10.1 Contract Research Organizations CROs
17.10.2 Clinical Trial Sponsors
17.11 Basis Point Share (BPS) Analysis by Application (Clinical Trial SponsorsContract Research Organizations
17.12 Absolute $ Opportunity Assessment by Application (Clinical Trial SponsorsContract Research Organizations
17.13 Market Attractiveness Analysis by Application (Clinical Trial SponsorsContract Research Organizations
17.14 Latin America ePRO, e-Patient Diaries and eCOA Market Size Forecast by Solution Type (eCOA
17.14.1 eCOA Electronic Clinical Outcome Assessments
17.15 Basis Point Share (BPS) Analysis by Solution Type (eCOA
17.16 Absolute $ Opportunity Assessment by Solution Type (eCOA
17.17 Market Attractiveness Analysis by Solution Type (eCOA
17.18 Latin America ePRO, e-Patient Diaries and eCOA Market Size Forecast by ObsROs
17.18.1 Observer Reported Outcomes
17.19 Basis Point Share (BPS) Analysis by ObsROs
17.20 Absolute $ Opportunity Assessment by ObsROs
17.21 Market Attractiveness Analysis by ObsROs
17.22 Latin America ePRO, e-Patient Diaries and eCOA Market Size Forecast by ClinROs
17.22.1 Clinician Reported Outcomes
17.23 Basis Point Share (BPS) Analysis by ClinROs
17.24 Absolute $ Opportunity Assessment by ClinROs
17.25 Market Attractiveness Analysis by ClinROs
17.26 Latin America ePRO, e-Patient Diaries and eCOA Market Size Forecast by EPROs
17.26.1 Patient Reported Outcomes
17.27 Basis Point Share (BPS) Analysis by EPROs
17.28 Absolute $ Opportunity Assessment by EPROs
17.29 Market Attractiveness Analysis by EPROs
17.30 Latin America ePRO, e-Patient Diaries and eCOA Market Size Forecast by Modality Type (Computer Mobile Devices
17.30.1 Tablets
17.30.2 Mobile Devices Smartphones
17.30.3 Computer
17.31 Basis Point Share (BPS) Analysis by Modality Type (Computer Mobile Devices
17.32 Absolute $ Opportunity Assessment by Modality Type (Computer Mobile Devices
17.33 Market Attractiveness Analysis by Modality Type (Computer Mobile Devices
Chapter 18 Middle East & Africa (MEA) ePRO, e-Patient Diaries and eCOA Analysis and Forecast
18.1 Introduction
18.2 Middle East & Africa (MEA) ePRO, e-Patient Diaries and eCOA Market Size Forecast by Country
18.2.1 Saudi Arabia
18.2.2 South Africa
18.2.3 UAE
18.2.4 Rest of Middle East & Africa (MEA)
18.3 Basis Point Share (BPS) Analysis by Country
18.4 Absolute $ Opportunity Assessment by Country
18.5 Market Attractiveness Analysis by Country
18.6 Middle East & Africa (MEA) ePRO, e-Patient Diaries and eCOA Market Size Forecast by PerfOs
18.6.1 Performance Outcomes
18.7 Basis Point Share (BPS) Analysis by PerfOs
18.8 Absolute $ Opportunity Assessment by PerfOs
18.9 Market Attractiveness Analysis by PerfOs
18.10 Middle East & Africa (MEA) ePRO, e-Patient Diaries and eCOA Market Size Forecast by Application (Clinical Trial SponsorsContract Research Organizations
18.10.1 Contract Research Organizations CROs
18.10.2 Clinical Trial Sponsors
18.11 Basis Point Share (BPS) Analysis by Application (Clinical Trial SponsorsContract Research Organizations
18.12 Absolute $ Opportunity Assessment by Application (Clinical Trial SponsorsContract Research Organizations
18.13 Market Attractiveness Analysis by Application (Clinical Trial SponsorsContract Research Organizations
18.14 Middle East & Africa (MEA) ePRO, e-Patient Diaries and eCOA Market Size Forecast by Solution Type (eCOA
18.14.1 eCOA Electronic Clinical Outcome Assessments
18.15 Basis Point Share (BPS) Analysis by Solution Type (eCOA
18.16 Absolute $ Opportunity Assessment by Solution Type (eCOA
18.17 Market Attractiveness Analysis by Solution Type (eCOA
18.18 Middle East & Africa (MEA) ePRO, e-Patient Diaries and eCOA Market Size Forecast by ObsROs
18.18.1 Observer Reported Outcomes
18.19 Basis Point Share (BPS) Analysis by ObsROs
18.20 Absolute $ Opportunity Assessment by ObsROs
18.21 Market Attractiveness Analysis by ObsROs
18.22 Middle East & Africa (MEA) ePRO, e-Patient Diaries and eCOA Market Size Forecast by ClinROs
18.22.1 Clinician Reported Outcomes
18.23 Basis Point Share (BPS) Analysis by ClinROs
18.24 Absolute $ Opportunity Assessment by ClinROs
18.25 Market Attractiveness Analysis by ClinROs
18.26 Middle East & Africa (MEA) ePRO, e-Patient Diaries and eCOA Market Size Forecast by EPROs
18.26.1 Patient Reported Outcomes
18.27 Basis Point Share (BPS) Analysis by EPROs
18.28 Absolute $ Opportunity Assessment by EPROs
18.29 Market Attractiveness Analysis by EPROs
18.30 Middle East & Africa (MEA) ePRO, e-Patient Diaries and eCOA Market Size Forecast by Modality Type (Computer Mobile Devices
18.30.1 Tablets
18.30.2 Mobile Devices Smartphones
18.30.3 Computer
18.31 Basis Point Share (BPS) Analysis by Modality Type (Computer Mobile Devices
18.32 Absolute $ Opportunity Assessment by Modality Type (Computer Mobile Devices
18.33 Market Attractiveness Analysis by Modality Type (Computer Mobile Devices
Chapter 19 Competition Landscape
19.1 ePRO, e-Patient Diaries and eCOA Market: Competitive Dashboard
19.2 Global ePRO, e-Patient Diaries and eCOA Market: Market Share Analysis, 2019
19.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
19.3.1 Medidata Solutions Inc.
19.3.2 ERT Clinical
19.3.3 Health Diary Inc.
19.3.4 PAREXEL International Corporation
19.3.5 OmniComm Systems Inc.
19.3.6 Major players analyzed include Bracket Global LLC
19.3.7 SAS
19.3.8 Kayentis
19.3.9 ICON plc
19.3.10 Others.
19.3.11 ArisGlobal LLC
19.3.12 CRF Health Inc.
Segments Covered in the Report
The global ePRO, e-Patient Diaries and eCOA market has been segmented based on
By PerfOs
The global ePRO, e-Patient Diaries and eCOA market has been segmented based on
By PerfOs
- Performance Outcomes
- Contract Research Organizations CROs
- Clinical Trial Sponsors
- eCOA Electronic Clinical Outcome Assessments
- Observer Reported Outcomes
- Clinician Reported Outcomes
- Patient Reported Outcomes
- Tablets
- Mobile Devices Smartphones
- Computer
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Medidata Solutions Inc.
- ERT Clinical
- Health Diary Inc.
- PAREXEL International Corporation
- OmniComm Systems Inc.
- Major players analyzed include Bracket Global LLC
- SAS
- Kayentis
- ICON plc
- Others.
- ArisGlobal LLC
- CRF Health Inc.
Our Clients
Related Reports
Some other reports from this category!
